Unapproved melanotan tanning sprays and “tan jabs” get marketed as melanocortin shortcuts. Scenesse (afamelanotide) is a different product: a prescription melanocortin 1 receptor (MC1-R) agonist implant labeled to increase pain-free light exposure in adults with erythropoietic protoporphyria (EPP) who have a history of phototoxic reactions. The everyday takeaway is clinic implant care plus continued sun-and-light protection and skin checks—not a cosmetic tanning peptide.
EPP phototoxicity is not a beach-tan problem
MedlinePlus describes erythropoietic protoporphyria as a rare porphyria in which light triggers burning pain in the skin. Scenesse is implanted by a trained clinician as a small bioresorbable rod under the skin above the hip area on a multi-month clinic schedule. It is not a nasal spray, not a research vial, and not approved as a general tanning or pigmentation cosmetic.
UniProt lists the melanocortin 1 receptor (Q01726) that afamelanotide is designed to activate. That receptor pathway can darken skin and moles, which is exactly why the approved label pairs treatment with dermatologic monitoring rather than promising “safe tanning.”
Implant clinic rules, light protection, and mole watches
The DailyMed label requires administration by a health professional trained in the implantation procedure. Serious hypersensitivity reactions, including anaphylaxis, have been reported after marketing; if a severe reaction occurs, emergency care and possible implant removal come first, and further Scenesse treatment is not continued. Because the medicine can darken pre-existing moles and freckles, a full-body skin exam twice a year is recommended to track old and new pigmented spots.
MedlinePlus drug information on afamelanotide and the label both stress that people should keep using sun and light protection measures during treatment so EPP phototoxic flares are still prevented. An implant does not replace shade, clothing, window films, or the light-avoidance plan your porphyria team already taught you.
Questions that change what you notice next. Before an implant visit, write down your EPP diagnosis, prior phototoxic reaction pattern, and any severe allergy history. Ask who places and, if needed, removes the implant, how to report swelling of lips/tongue/breathing trouble the same hour, when the next full-body skin check is booked, and which light-protection steps stay mandatory. Carry a note that Scenesse is an MC1-R agonist implant for adult EPP—not a melanotan-style tanning product—so urgent care does not treat it as elective cosmetics.
Not medical advice.
Sources
- DailyMed: Scenesse (afamelanotide) prescribing information
- MedlinePlus: Erythropoietic protoporphyria
- MedlinePlus: Afamelanotide
- UniProt: Melanocortin 1 receptor (Q01726)
Related reading
- Melanotan tanning sprays and mole changes
- Vyleesi desire shot nausea and blood pressure
- IV glutathione skin-lightening drip FDA warning
By The Everyday Brief. AI-assisted drafting with human editorial review. Sources fetched 2026-10-11 PT. Not medical advice.